Noom offers cut-price compounded GLP-1 drug for obesity Digital health company Noom has launched a compound pharmacy-made version of Novo Nordisk's obesity drug semaglutide to make the drug more accessible to consumers in the US
That said, there are lesser-discussed side effects worth paying attention to, such as the risk of dehydration
3 That combination matters because appetite, cravings, blood sugar, and energy are not separate issues
The principles cited above are consistent with published FY2026 ICD-10-CM Official Guidelines
Yes, all FDA-approved weight loss medications require a prescription from a licensed healthcare provider
Your attorney will review imaging, medication records, and expert findings to determine whether the evidence supports a pharmaceutical injury claim